NZ183462A - Prostanoic ergolin-8-ylalkyl esters, thioesters and amides: preparation and pharmaceutical compositions - Google Patents
Prostanoic ergolin-8-ylalkyl esters, thioesters and amides: preparation and pharmaceutical compositionsInfo
- Publication number
- NZ183462A NZ183462A NZ183462A NZ18346277A NZ183462A NZ 183462 A NZ183462 A NZ 183462A NZ 183462 A NZ183462 A NZ 183462A NZ 18346277 A NZ18346277 A NZ 18346277A NZ 183462 A NZ183462 A NZ 183462A
- Authority
- NZ
- New Zealand
- Prior art keywords
- ergolin
- ylalkyl
- prostanoic
- thioesters
- amides
- Prior art date
Links
- 150000001408 amides Chemical class 0.000 title 1
- 150000002148 esters Chemical class 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 150000007970 thio esters Chemical class 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/62—Oxygen or sulfur atoms
- C07D213/70—Sulfur atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
- C07C405/0008—Analogues having the carboxyl group in the side-chains replaced by other functional groups
- C07C405/0033—Analogues having the carboxyl group in the side-chains replaced by other functional groups containing sulfur
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D457/00—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid
- C07D457/02—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid with hydrocarbon or substituted hydrocarbon radicals, attached in position 8
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/26—Heterocyclic compounds containing purine ring systems with an oxygen, sulphur, or nitrogen atom directly attached in position 2 or 6, but not in both
- C07D473/32—Nitrogen atom
- C07D473/34—Nitrogen atom attached in position 6, e.g. adenine
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CH526876 | 1976-04-27 |
Publications (1)
Publication Number | Publication Date |
---|---|
NZ183462A true NZ183462A (en) | 1979-10-25 |
Family
ID=4290745
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NZ183462A NZ183462A (en) | 1976-04-27 | 1977-02-28 | Prostanoic ergolin-8-ylalkyl esters, thioesters and amides: preparation and pharmaceutical compositions |
Country Status (13)
Country | Link |
---|---|
JP (1) | JPS52131600A (en) |
BE (1) | BE852055A (en) |
DE (1) | DE2707915A1 (en) |
DK (1) | DK75177A (en) |
FI (1) | FI770572A (en) |
FR (2) | FR2353549A1 (en) |
GB (1) | GB1577647A (en) |
IL (1) | IL51561A0 (en) |
NL (1) | NL7702221A (en) |
NZ (1) | NZ183462A (en) |
PT (1) | PT66269B (en) |
SU (1) | SU741794A3 (en) |
ZA (1) | ZA771215B (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
HU196598B (en) * | 1986-04-25 | 1988-12-28 | Richter Gedeon Vegyeszet | Process for producing 1- and/or 8-substituted 2-halogenated ergoline derivatives and pharmaceutics comprising such compounds |
-
1977
- 1977-02-21 DK DK75177A patent/DK75177A/en unknown
- 1977-02-22 FI FI770572A patent/FI770572A/fi not_active Application Discontinuation
- 1977-02-24 DE DE19772707915 patent/DE2707915A1/en not_active Withdrawn
- 1977-02-25 GB GB7981/77A patent/GB1577647A/en not_active Expired
- 1977-02-28 NZ NZ183462A patent/NZ183462A/en unknown
- 1977-02-28 IL IL51561A patent/IL51561A0/en unknown
- 1977-03-01 ZA ZA00771215A patent/ZA771215B/en unknown
- 1977-03-02 NL NL7702221A patent/NL7702221A/en not_active Application Discontinuation
- 1977-03-03 FR FR7706181A patent/FR2353549A1/en not_active Withdrawn
- 1977-03-03 SU SU772457126A patent/SU741794A3/en active
- 1977-03-03 PT PT66269A patent/PT66269B/en unknown
- 1977-03-03 JP JP2225977A patent/JPS52131600A/en active Pending
- 1977-03-03 BE BE175449A patent/BE852055A/en unknown
- 1977-08-30 FR FR7726295A patent/FR2355837A1/en not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
DK75177A (en) | 1977-10-28 |
NL7702221A (en) | 1977-10-31 |
DE2707915A1 (en) | 1977-11-17 |
IL51561A0 (en) | 1977-04-29 |
PT66269A (en) | 1977-04-01 |
GB1577647A (en) | 1980-10-29 |
BE852055A (en) | 1977-09-05 |
SU741794A3 (en) | 1980-06-15 |
ZA771215B (en) | 1978-10-25 |
FI770572A (en) | 1977-10-28 |
PT66269B (en) | 1978-11-07 |
FR2353549A1 (en) | 1977-12-30 |
FR2355837A1 (en) | 1978-01-20 |
JPS52131600A (en) | 1977-11-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL51450A (en) | Cefuroxime esters,their preparation and pharmaceutical compositions containing them | |
NZ185986A (en) | 2-oxa-bicyclic prostag-landins and pharmaceutical compositions | |
IL52258A (en) | Monic acid esters,their preparation and pharmaceutical compositions containing them | |
NZ183551A (en) | Aminochromanols and pharmaceutical compositions containingthem | |
NZ183150A (en) | 7-aminothiazolyl-iminoa-cetamido-cephalosporin derivatives and pharmaceutical compositions | |
NZ185358A (en) | Spiro-hydantoins and pharmaceutical compositions | |
NZ187849A (en) | Prostaglandin i derivatives and pharmaceutical compositions | |
PH16512A (en) | N-(phenylalkylamino-alkyl)-dihydroisoquinolinones,pharmaceutical compositions and methods employing them | |
NZ184428A (en) | N-acyl-l-alanyl-aminoacyl-amides untermediates and pharmaceutical compositions | |
IL49325A0 (en) | Novel prostaglandin derivatives,their preparation and pharmaceutical compositions containing them | |
NZ184263A (en) | N-(amino-alkyl-amino)-benzamides and pharmaceutical compositions | |
NZ186119A (en) | 7-alkoxycarbonyl-6-alkyl/halo-17-hydoxy-3-oxo-17 -pregn-4-ene-21-carboxylic acid derivatives and pharmaceutical compositions | |
NZ184755A (en) | 2-benzylpyrrolidine derivatives and pharmaceutical compositions | |
NZ184912A (en) | 2-phenylamino-imidazolines and pharmaceutical compositions | |
IL51428A (en) | 3-substituted-4-aminoalkoxy-5,6-condensed ring-(2h)-pyran-2-ones,their preparation and pharmaceutical compositions containing them | |
NZ184102A (en) | Derivatives of benzenesulphonylurea,and pharmaceutical compositions | |
NZ184103A (en) | Fenzodioxole derivatives and pharmaceutical compositions | |
NZ185539A (en) | Cis-4a-aryl-2-substituted-2,3,4,4a,5,6,7,7a-octa hydro-1h-2-pyrindines and pharmaceutical compositions | |
NZ183549A (en) | Amidinopencillanoyloxy-alkyl-amoxycillinates and pharmaceutical compositions | |
NZ186059A (en) | 3-sulphamoyl-5-pyrrolylal-kylbenzoic acid derivatives and pharmaceutical compositions | |
IL53552A (en) | 1-piperazinopropanol esters,their preparation and pharmaceutical compositions containing them | |
NZ183462A (en) | Prostanoic ergolin-8-ylalkyl esters, thioesters and amides: preparation and pharmaceutical compositions | |
IL53342A (en) | Monocyclic -lactams,their preparation and pharmaceutical compositions containing -lactams having anitbacterial activite | |
NZ183756A (en) | Bis-penicillanoyloxy-alkanes and pharmaceutical compositions | |
NZ184367A (en) | 2-vinyl-chromone derivatives and pharmaceutical compositions |